Lexicon Pharmaceuticals
LXRX
LXRX
112 hedge funds and large institutions have $206M invested in Lexicon Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
12.54% less ownership
Funds ownership: 89.62% → 77.08% (-13%)
48% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 21
53% less capital invested
Capital invested by funds: $438M → $206M (-$232M)
Holders
112
Holding in Top 10
1
Calls
$441K
Puts
$291K
Top Buyers
| 1 | +$1.36M | |
| 2 | +$564K | |
| 3 | +$410K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$311K |
| 5 |
BlackRock
New York
|
+$301K |
Top Sellers
| 1 | -$1.34M | |
| 2 | -$1.2M | |
| 3 | -$1.15M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.03M |
| 5 |
Axa
Paris,
France
|
-$816K |